unknown
Stage
About
ARase Therapeutics is a science-focused oncology company developing first-in-class therapeutics targeting ADP-ribose hydrolases, which are involved in cancer signaling and stress pathways.
Explore ARase Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.